Title |
Antiviral Activity of Resveratrol against Human and Animal Viruses
|
---|---|
Published in |
Advances in Virology, November 2015
|
DOI | 10.1155/2015/184241 |
Pubmed ID | |
Authors |
Yusuf Abba, Hasliza Hassim, Hazilawati Hamzah, Mohamed Mustapha Noordin |
Abstract |
Resveratrol is a potent polyphenolic compound that is being extensively studied in the amelioration of viral infections both in vitro and in vivo. Its antioxidant effect is mainly elicited through inhibition of important gene pathways like the NF-κβ pathway, while its antiviral effects are associated with inhibitions of viral replication, protein synthesis, gene expression, and nucleic acid synthesis. Although the beneficial roles of resveratrol in several viral diseases have been well documented, a few adverse effects have been reported as well. This review highlights the antiviral mechanisms of resveratrol in human and animal viral infections and how some of these effects are associated with the antioxidant properties of the compound. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Germany | 3 | 17% |
United States | 2 | 11% |
France | 1 | 6% |
Unknown | 12 | 67% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 14 | 78% |
Science communicators (journalists, bloggers, editors) | 2 | 11% |
Scientists | 2 | 11% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 139 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 22 | 16% |
Researcher | 19 | 14% |
Student > Bachelor | 15 | 11% |
Student > Master | 12 | 9% |
Student > Doctoral Student | 9 | 6% |
Other | 32 | 23% |
Unknown | 30 | 22% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 25 | 18% |
Agricultural and Biological Sciences | 18 | 13% |
Medicine and Dentistry | 12 | 9% |
Pharmacology, Toxicology and Pharmaceutical Science | 11 | 8% |
Immunology and Microbiology | 10 | 7% |
Other | 23 | 17% |
Unknown | 40 | 29% |